DG Health Artifical Tears (Dolgencorp Inc.)
Welcome to the PulseAid listing for the DG Health Artifical Tears drug offered from Dolgencorp Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dolgencorp Inc. |
NON-PROPRIETARY NAME: | Glycerin, Hypromellose, and Polyethylene glycol 400 |
SUBSTANCE NAME: | GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400 |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2017-02-27 |
END MARKETING DATE: | 0000-00-00 |
DG Health Artifical Tears HUMAN OTC DRUG Details:
Item Description | DG Health Artifical Tears from Dolgencorp Inc. |
LABELER NAME: | Dolgencorp Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5; 2; 11.28(mg/mL; mg/mL; mg/mL) |
START MARKETING DATE: | 2017-02-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55910-644_88527eb4-441f-46b8-8a1c-9ac196f02039 |
PRODUCT NDC: | 55910-644 |
APPLICATION NUMBER: | part349 |
Other GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400 Pharmaceutical Manufacturers / Labelers: